Home/Neuropeutics/Dhruv Mehta, HBSc
DM

Dhruv Mehta, HBSc

Research Assistant

Neuropeutics

Neuropeutics Pipeline

DrugIndicationPhase
JRMS-22Amyotrophic Lateral Sclerosis (ALS)Preclinical